Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocol.
Civil YA, Oei AL, Duvivier KM, Bijker N, Meijnen P, Donkers L, Verheijen S, van Kesteren Z, Palacios MA, Schijf LJ, Barbé E, Konings IRHM, -van der Houven van Oordt CWM, Westhoff PG, Meijer HJM, Diepenhorst GMP, Thijssen V, Mouliere F, Slotman BJ, van der Velde S, van den Bongard HJGD. Civil YA, et al. Among authors: thijssen v. BMC Cancer. 2023 May 9;23(1):419. doi: 10.1186/s12885-023-10910-6. BMC Cancer. 2023. PMID: 37161377 Free PMC article.
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.
Goedegebuure RSA, Kleibeuker EA, Buffa FM, Castricum KCM, Haider S, Schulkens IA, Ten Kroode L, van den Berg J, Jacobs MAJM, van Berkel AM, van Grieken NCT, Derks S, Slotman BJ, Verheul HMW, Harris AL, Thijssen VL. Goedegebuure RSA, et al. J Exp Clin Cancer Res. 2021 May 8;40(1):161. doi: 10.1186/s13046-021-01962-2. J Exp Clin Cancer Res. 2021. PMID: 33964942 Free PMC article.
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.
Kleibeuker EA, Fokas E, Allen PD, Kersemans V, Griffioen AW, Beech J, Im JH, Smart SC, Castricum KC, van den Berg J, Schulkens IA, Hill SA, Harris AL, Slotman BJ, Verheul HM, Muschel RJ, Thijssen VL. Kleibeuker EA, et al. Among authors: thijssen vl. Oncotarget. 2016 Nov 22;7(47):76613-76627. doi: 10.18632/oncotarget.12814. Oncotarget. 2016. PMID: 27780936 Free PMC article.
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).
Stroes CI, Schokker S, Khurshed M, van der Woude SO, Mathôt RA, Slingerland M, de Vos-Geelen J, Zucchetti M, Matteo C, van Dijk E, Ylstra B, Thijssen V, Derks S, Godefa T, Dijksterhuis W, Breimer GE, van Delden OM, Verhoeven RH, Meijer SL, Bijlsma MF, van Laarhoven HW. Stroes CI, et al. Among authors: thijssen v. Ther Adv Med Oncol. 2022 Jun 28;14:17588359221109196. doi: 10.1177/17588359221109196. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35782751 Free PMC article.
Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.
Femel J, van Hooren L, Herre M, Cedervall J, Saupe F, Huijbers EJM, Verboogen DRJ, Reichel M, Thijssen VL, Griffioen AW, Hellman L, Dimberg A, Olsson AK. Femel J, et al. Cancer Immunol Immunother. 2022 Oct;71(10):2581. doi: 10.1007/s00262-022-03175-8. Cancer Immunol Immunother. 2022. PMID: 35226107 Free PMC article. No abstract available.
Combining radiotherapy with sunitinib: lessons (to be) learned.
Kleibeuker EA, Ten Hooven MA, Verheul HM, Slotman BJ, Thijssen VL. Kleibeuker EA, et al. Angiogenesis. 2015 Oct;18(4):385-95. doi: 10.1007/s10456-015-9476-3. Epub 2015 Jul 23. Angiogenesis. 2015. PMID: 26202788 Free PMC article. Review.
107 results